Robb Gary Charles Insider Trading Activity

Average Profitability
72.23%
Insider Buys Quantity
1
Insider Buys Sum
$54,588.24
Insider Sells Quantity
27
Insider Sells Sum
$12.42M

Insider Activity of Robb Gary Charles

According to the SEC Form 4 filings, Robb Gary Charles, being in a position of

  1. Chief Business Officer at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 10000 shares for $1.16M,
    over all time since 2017-05-04, has bought 5600 shares for $54,588, and sold 494109 shares for $14.14M.

Biography of Robb Gary Charles

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,162,5721100

Comparison of Insiders on Amount of Buys and Sells

2026-08-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
10,000
0.0094%
$116.26$1.16M-2.07%
2025-08-22SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
2,326
0.0022%
$71.27$165,774+2.64%
2025-06-16SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
3,185
0.003%
$70.77$225,402-1%
2025-05-20SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
2,279
0.0021%
$75.85$172,862-7.73%
2025-01-02SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0106%
$50.50$555,552+43.27%
2024-11-22SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
2,609
0.0024%
$56.20$146,626+22.68%
2024-10-01SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0113%
$46.28$509,080+45.84%
2024-08-26SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
3,101
0.003%
$35.71$110,737+74.23%
2024-07-01SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0109%
$32.49$357,390+70.51%
2024-05-28SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0102%
$30.39$334,294+64.46%
2023-12-06SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,212
0.006%
$27.01$167,786+15.63%
2023-12-05SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
1,381
0.0013%
$26.27$36,277+17.99%
2023-09-19SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
5,000
0.0048%
$32.74$163,677-17.21%
2023-05-10SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
14,000
0.013%
$24.07$336,980+3.6%
2023-05-09SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
30,000
0.0279%
$23.87$716,100+4.2%
2022-11-23SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
186
0.0002%
$26.03$4,842-9.7%
2022-11-22SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
4,814
0.0045%
$26.03$125,308-9.79%
2022-11-18SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
13,401
0.0124%
$26.43$354,188-11.47%
2022-11-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
10,000
0.0093%
$26.06$260,600-9.55%
2022-09-07SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
50,000
0.0462%
$26.06$1.3M-10.79%
Total: 32
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.